Twenty years ago this month, the Lung Transplant Program at Texas Children's Hospital was launched. Since October 2002, Texas Children's transplant team has performed 240 pediatric lung transplants. "We are honored to meet this remarkable milestone — it's not just about the number of transplants our team has performed; it's about how many children's lives have been saved through the Lung Transplant Program here at Texas Children's Hospital," s

Aster CMI Hospital, one of the renowned healthcare institutes in the city announced the launch of Lifestyle Medicine Program (LMP) today to help people with various lifestyle diseases and better manage their condition. The hospital is also setting up a new department that focuses on providing medical treatment and care on these lines. This LMP is the first hospital-based, physician-led lifestyle program conducted for the first time in India. C. N. Ashwath Narayan, Minister of Skill Developmen

Verily, an Alphabet company focused on precision health, and the Crohn’s & Colitis Foundation, a non-profit organization dedicated to finding cures for Crohn’s disease and ulcerative colitis and to improving the quality of life of children and adults affected by these diseases, announced today an expanded strategic partnership. The collaboration will focus on building a longitudinal registry to accelerate research in Crohn’s disease and in ulcerative colitis, collectivel

Hugel America, Inc. (Hugel Aesthetics) announced today the acceptance of its Biologics License Application for letibotulinumtoxinA, by the U.S. Food and Drug Administration (“FDA”). The FDA considered the resubmission a Class 2 response and has assigned a April 6, 2023 action date per the Prescription Drug User Fee Act (PDUFA). Jim Hartman, President of Hugel Aesthetics, stated, “We have worked diligently to advance our regulatory submission of letibotulinumtoxinA.

Brainlab, a digital medical technology company, and the German Society for Orthopedics and Orthopedic Surgery (DGOOC) will work together in the field of data privacy-compliant registry solutions. Through a partnership between Mint Medical GmbH, a Brainlab company, and the newly founded RSG Register Solutions gGmbH (RSG), a non-profit subsidiary of the DGOOC, Brainlab and DGOOC will have the opportunity to combine their expertise. Mint Medical is specialized in the computer-aided analysis of r

Naveris, Inc., a leader in molecular diagnostics for viral cancers, today announced that the company and the principle investigator at Mayo Clinic will present its award-winning abstract at the American Society for Radiation Oncology (ASTRO) Annual Meeting held October 23-26, 2022. This presentation describes significant new data supporting the clinical value of NavDx®, the first and only clinically validated circulating tumor-tissue-modified HPV (TTMV®) DNA blood test, as a non-invas

OSF HealthCare selected CareSignal, a Lightbeam company, to offer Deviceless Remote Patient Monitoring® (RPM) and help power its enterprise-wide digital health solution, OSF OnCall Connect. The Deviceless RPM solution will extend the reach of its care management services to rising-risk patient populations and remotely monitor the whole health of patients with chronic condition-specific programs for asthma, diabetes, chronic obstructive pulmonary disease (COPD), congestive heart failure (C

Sol-Millennium Inc., a medical device company and innovator in medication delivery and specimen collection, announced it has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its proprietary Sol-Guard® Safety Pull Button Blood Collection Set, the newest safety device in the company's rapidly expanding blood collection portfolio. The Sol-Guard® Safety Pull Button Blood Collection Set features spring-activated needle retraction technology, designed

One of the most advanced AI-based image analysis platforms for bone disease diagnostics will get rolled out at the radiology and orthopedic departments of the University Hospital of the Ludwig-Maximilian University Munich (LMU Hospital), Germany. The innovative analysis tool is already in clinical use at several other medical and academic institutions throughout the EU and US. The AI based platform allows for standardized, effective and precise assessment of chronic musculoskeletal (MSK) dise

Paragonix Technologies, Inc., a leader in Advanced Organ Preservation (AOP) technology, has announced the launch of its new VantagePoint™ Organ Tracking Technology to pioneer a new era of continuous oversight and real-time visibility for donor organs in transit. Designed to meet the rising standards of transparency and accountability in donor organ transportation, this technology will improve the digital tracking capabilities provided by the Paragonix App, the free-to-download software,